IceCure Medical reported revenue of $0.91M and net income of $4.50M for the quarter ended Jun 2026, up 72.8% year over year. This income statement covers 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||||
| Revenue | 0.68M | 1.38M | 0.75M | 0.77M | 0.63M | 0.94M | 0.71M | 0.94M | 0.33M | 1.25M | 0.74M | 1.01M | 0.66M | 0.88M | 0.72M | 0.53M | 0.85M | 1.28M | 0.91M | 0.91M | ||||
| Cost of RevenueCost of Rev | 0.32M | 0.74M | 0.31M | 0.38M | 0.47M | 0.48M | 0.39M | 0.50M | 0.35M | 0.69M | 0.47M | 0.48M | 0.43M | 0.46M | 0.51M | 0.39M | 0.57M | 0.68M | 0.62M | 0.65M | ||||
| Gross Profit | 0.36M | 0.64M | 0.43M | 0.38M | 0.17M | 0.46M | 0.32M | 0.43M | -0.02M | 0.57M | 0.27M | 0.53M | 0.23M | 0.42M | 0.22M | 0.13M | 0.28M | 0.60M | 0.29M | 0.25M | ||||
| Operating items | ||||||||||||||||||||||||
| Research & DevelopmentR&D | 1.55M | 1.60M | 2.39M | 2.25M | 2.24M | 2.24M | 2.11M | 2.08M | 2.20M | 1.88M | 1.95M | 1.58M | 1.86M | 1.70M | 1.66M | 1.71M | 1.76M | 2.30M | 2.21M | 2.07M | ||||
| Selling, General & AdministrativeSG&A | 1.07M | 1.47M | 1.72M | 1.62M | 1.32M | 1.19M | 1.09M | 1.26M | 0.92M | 0.90M | 0.93M | 0.92M | 0.92M | 0.99M | 0.92M | 0.95M | 1.44M | 1.22M | 1.26M | 1.16M | ||||
| Operating ExpensesOpex | 2.62M | 3.07M | 4.11M | 3.88M | 3.56M | 3.43M | 3.20M | 3.34M | 3.12M | 2.78M | 2.88M | 2.50M | 2.78M | 2.69M | 2.59M | 2.66M | 3.20M | 3.52M | 3.47M | 3.23M | ||||
| Operating IncomeOp. Inc | 2.85M | 3.13M | 4.42M | 4.28M | 4.10M | 3.93M | 3.96M | 4.08M | 4.12M | 3.42M | 3.65M | 3.23M | 4.29M | 4.53M | 3.66M | 3.38M | 3.84M | 4.22M | 4.25M | 4.42M | ||||
| EBIT | 2.85M | 3.13M | 4.42M | 4.28M | 4.10M | 3.93M | 3.96M | 4.08M | 4.12M | 3.42M | 3.65M | 3.23M | 4.29M | 4.53M | 3.66M | 3.38M | 3.84M | 4.22M | 4.25M | 4.42M | ||||
| Non-operating items | ||||||||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | 0.04M | 0.03M | 0.02M | 0.24M | -0.04M | 0.02M | -0.19M | -0.19M | -0.12M | -0.42M | -0.04M | -0.15M | -0.14M | -0.05M | -0.07M | -0.02M | 0.02M | 0.03M | 0.03M | 0.08M | ||||
| Net income details | ||||||||||||||||||||||||
| EBT | 2.85M | 3.13M | 4.42M | 4.28M | 4.10M | 3.93M | 3.96M | 4.08M | 4.12M | 3.42M | 3.65M | 3.23M | 4.29M | 4.53M | 3.66M | 3.38M | 3.84M | 4.22M | 4.25M | 4.42M | ||||
| Profit After TaxPAT | 2.89M | 3.16M | 4.45M | 4.52M | 4.06M | 3.95M | 3.77M | 3.89M | 4.00M | 3.00M | 3.61M | 3.08M | 4.15M | 4.48M | 3.59M | 3.36M | 3.86M | 4.25M | 4.27M | 4.50M | ||||
| Income from Continuing OperationsIncome (Continuing) | 2.85M | 3.13M | 4.42M | 4.28M | 4.10M | 3.93M | 3.96M | 4.08M | 4.12M | 3.42M | 3.65M | 3.23M | 4.29M | 4.53M | 3.66M | 3.38M | 3.84M | 4.22M | 4.25M | 4.42M | ||||
| Consolidated Net IncomeConsol Net Inc. | 2.85M | 3.13M | 4.42M | 4.28M | 4.10M | 3.93M | 3.96M | 4.08M | 4.12M | 3.42M | 3.65M | 3.23M | 4.29M | 4.53M | 3.66M | 3.38M | 3.84M | 4.22M | 4.25M | 4.42M | ||||
| Income towards Parent CompanyParent Net Inc | 2.85M | 3.13M | 4.42M | 4.28M | 4.10M | 3.93M | 3.96M | 4.08M | 4.12M | 3.42M | 3.65M | 3.23M | 4.29M | 4.53M | 3.66M | 3.38M | 3.84M | 4.22M | 4.25M | 4.42M | ||||
| Net Income towards Common StockholdersNet Income | 2.85M | 3.13M | 4.42M | 4.28M | 4.10M | 3.93M | 3.96M | 4.08M | 4.12M | 3.42M | 3.65M | 3.23M | 4.29M | 4.53M | 3.66M | 3.38M | 3.84M | 4.22M | 4.25M | 4.42M | ||||
| Additional items | ||||||||||||||||||||||||
| EPS (Basic) | 4.99 | 3.29 | 4.65 | 4.50 | 4.31 | 3.19 | 3.21 | 3.31 | 3.34 | 2.24 | 2.40 | 2.12 | 2.82 | 2.67 | 2.16 | 2.00 | 2.26 | 1.99 | 2.00 | 2.09 | ||||
| EPS (Diluted) | 4.99 | 3.29 | 4.65 | 4.50 | 4.31 | 3.19 | 3.21 | 3.31 | 3.34 | 2.24 | 2.40 | 2.12 | 2.82 | 2.67 | 2.16 | 2.00 | 2.26 | 1.99 | 2.00 | 2.09 | ||||
| Shares Outstanding | 0.57M | 0.95M | 0.95M | 0.95M | 0.95M | 1.23M | 1.23M | 1.23M | 1.23M | 1.52M | 1.52M | 1.52M | 1.52M | 1.70M | 1.70M | 1.70M | 1.70M | 2.12M | 2.12M | 2.12M | ||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.57M | 0.95M | 0.95M | 0.95M | 0.95M | 1.23M | 1.23M | 1.23M | 1.23M | 1.52M | 1.52M | 1.52M | 1.52M | 1.70M | 1.70M | 1.70M | 1.70M | 2.12M | 2.12M | 2.12M | ||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.95M | 1.23M | 1.52M | 1.89M | 2.44M | |||||||||||||||||||
| EBITDA | 2.85M | 3.13M | 4.42M | 4.28M | 4.10M | 3.93M | 3.96M | 4.08M | 4.12M | 3.42M | 3.65M | 3.23M | 4.29M | 4.53M | 3.66M | 3.38M | 3.84M | 4.22M | 4.25M | 4.42M |